ly 300164 has been researched along with 4-aminopyridine in 2 studies
Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (4-aminopyridine) | Trials (4-aminopyridine) | Recent Studies (post-2010) (4-aminopyridine) |
---|---|---|---|---|---|
73 | 7 | 12 | 4,141 | 134 | 804 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carcache, D; Kalkman, HO; Koller, M; Mattes, H | 1 |
Kardos, J; Kovács, I; Skuban, N; Szárics, E | 1 |
2 other study(ies) available for ly 300164 and 4-aminopyridine
Article | Year |
---|---|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA | 2010 |
Deramciclane inhibits N-methyl-D-aspartate receptor function.
Topics: 4-Aminopyridine; Animals; Anti-Anxiety Agents; Aspartic Acid; Benzodiazepines; Calcium; Camphanes; Cerebral Cortex; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Magnesium; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |